The cerebral cortex of Alzheimer's and Down syndrome patients is characterized by the
presence of protein deposits in neurofibrillary tangles, neuritic plaques, and neuropil threads. …

One of the major therapeutic challenges in the arena of interventional cardiology is to
design strategies aimed at reducing myocardial tissue damage after myocardial infarction. In …

Our knowledge concerning the primary structures of crustacean neuropeptides has been
broadened considerably during the last few years and has greatly contributed to the successful …

Human ESC-derived mesenchymal stem cell (MSC)-conditioned medium (CM) was previously
shown to mediate cardioprotection during myocardial ischemia/reperfusion injury through …

Background— Identification of patients at risk for primary and secondary manifestations of
atherosclerotic disease progression is based mainly on established risk factors. The …

Left ventricular (LV) remodeling leads to congestive heart failure and is a main determinant
of morbidity and mortality following myocardial infarction. Therapeutic options to prevent LV …

Although paracrine effects of mesenchymal stem cells (MSCs) have been suggested previously,
cardioprotection by human MSC secretions has never been demonstrated. Human MSC…

Objectives : This study sought to examine whether exenatide is capable of reducing myocardial
infarct size. Background : Exenatide is a glucagon-like peptide (GLP)-1 analogue with …

Recent studies suggest that the therapeutic effects of stem cell transplantation following
myocardial infarction (MI) are mediated by paracrine factors. One of the main goals in the …

Background— Reperfusion therapy for myocardial infarction is hampered by detrimental
inflammatory responses partly via Toll-like receptor (TLR) activation. Targeting TLR signaling …